Clinical Trial

A Phase II Study of AK146D1 Mono or Combined With AK112 in Advanced Urothelial Carcinoma

Name: A Phase II Study of AK146D1 Mono or Combined With AK112 in Advanced Urothelial Carcinoma — clinical trial record (NCT07636772)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This is a Phase II clinical study aimed at evaluating the safety, tolerability, antitumor efficacy, PK and immunogenicity of AK146D1 monotherapy or combined with AK112 in advanced Urothelial carcinoma.

Trial Details

NCT Number	NCT07636772
Lead Sponsor	Akeso
Conditions	Urothelial Carcinoma (UC)
Enrollment	132 participants
Start Date	2026-06-22
Primary Completion	2028-08-24 (estimated)
Study Completion	2028-08-24 (estimated)
Updated on ClinicalTrials.gov	2026-06-09